Keywords: beaufour, ipsen, octagen, collaborate, announced, collaboration, tocommercialize

Beaufour Ipsen and Octagen collaborate

Article | 29 October 1998

Beaufour Ipsen and Octagen have announced a collaboration tocommercialize improved treatments for hemophilia, utilizing Octagen's second-generation genetically-engineered Factor VIII. The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Ipsen

Go to company listing